Minerva Neurosciences, Inc. (NERV)
2.32
+0.08
(+3.57%)
USD |
NASDAQ |
Oct 30, 16:00
2.30
-0.02
(-0.86%)
After-Hours: 20:00
Minerva Neurosciences Cash from Investing (Quarterly) : -4.833M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.833M |
| March 31, 2026 | -45.29M |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | -0.0163M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 3.00M |
| June 30, 2020 | 4.50M |
| Date | Value |
|---|---|
| March 31, 2020 | 17.03M |
| December 31, 2019 | -2.312M |
| September 30, 2019 | 19.58M |
| June 30, 2019 | 7.366M |
| March 31, 2019 | -10.55M |
| December 31, 2018 | -27.43M |
| September 30, 2018 | 29.50M |
| June 30, 2018 | 36.10M |
| March 31, 2018 | 31.32M |
| December 31, 2017 | -0.0239M |
| September 30, 2017 | -79.80M |
| June 30, 2017 | -10.89M |
| March 31, 2017 | -16.48M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 8.375M |
| June 30, 2016 | 1.40M |
| March 31, 2016 | 8.043M |
| December 31, 2015 | 4.095M |
| September 30, 2015 | 0.828M |
| June 30, 2015 | -23.20M |
| March 31, 2015 | -0.005M |
| December 31, 2014 | -0.0469M |
| September 30, 2014 | -0.0337M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 1.168M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Heron Therapeutics, Inc. | -3.265M |
| Tonix Pharmaceuticals Holding Corp. | -0.5769M |
| Karyopharm Therapeutics, Inc. | -10.04M |
| Corbus Pharmaceuticals Holdings, Inc. | 18.26M |
| Ocugen, Inc. | -0.021M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -13.34M |
| Cash from Financing (Quarterly) | 10.17M |
| Free Cash Flow | -26.17M |
| Free Cash Flow Per Share (Quarterly) | -0.1687 |
| Free Cash Flow to Equity (Quarterly) | -20.12M |
| Free Cash Flow to Firm (Quarterly) | -13.34M |
| Free Cash Flow Yield | -31.84% |